HHS Adds Duchenne Muscular Dystrophy, Metachromatic Leukodystrophy to Newborn Screening Panel
The additions aim to enable earlier detection and treatment of both rare conditions, which typically aren’t diagnosed until ages 4-5.
Read MorePosted by CLP Edit Staff | Dec 17, 2025 | Disease States |
The additions aim to enable earlier detection and treatment of both rare conditions, which typically aren’t diagnosed until ages 4-5.
Read MorePosted by CLP Edit Staff | Dec 16, 2025 | Infectious Diseases |
The collaboration aims to create a non-invasive diagnostic for Pseudomonas aeruginosa using miniaturized gas chromatography-mass spectrometry technology.
Read MorePosted by CLP Edit Staff | Dec 16, 2025 | Urinalysis & Toxicology |
Researchers have developed a direct urine testing approach that bypasses traditional bacterial culture requirements.
Read MorePosted by CLP Edit Staff | Dec 12, 2025 | Anatomic Pathology |
The study consolidating data from six published studies confirms the test outperforms traditional pathology or clinical factors alone in identifying esophageal cancer risk.
Read MorePosted by CLP Edit Staff | Dec 12, 2025 | Molecular Diagnostics |
Hospital teams can trial the company’s BSI/AMR test and preview the LiDia-SEQ system ahead of commercial launch.
Read More